THIS IS A NOTICE OF INTENT, NOT A REQUEST FOR A PROPOSAL. A SOLICITATION DOCUMENT WILL NOT BE ISSUED AND PROPOSALS WILL NOT BE REQUESTED. The National Heart, Lung, and Blood Institute (NHLBI) Office of Acquisition (OA) intends to negotiate and award a purchase order on a noncompetitive sole source basis to Fenwal Blood Technologies, Three Corporate Drive, Lake Zurich, IL 60047. The reference number NHLBI-PB-(HL)-2009-269-DDC. The items to be purchase are: Product Code, 4R2210T, CS3000 Open System Kit, quantity 110 cases The Government=s estimated expected delivery date is 90 days after receipt of the purchase order. The delivery point is the National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), Bethesda, Maryland. The sole source is based on the fact that Fenwal Blood Technology is the manufacture of Aphaeresis kits. The kits are to be used with an existing instrumentation (CS3000 cell separator) in order to perform leukapheresis procedures on non-human primates over the coming years. The kits are to be discontinued by the manufacture and no other company can or will be able to provide the kits that are compatible with existing equipment. This requirement is under the North American Industry Classification System (NAICS) 325412 Pharmaceutical Preparation Manufacturing Standard is 750 employees. The Small Business Set-Aside does not apply. The delivery and acceptance is F.O. B. Point is 5 Research Ct., Rm. 1A36, Rockville, MD This acquisition is being conducted under simplified acquisition procedures, and exempt from the requirements of FAR Part 6. This notice of intent is not a request for competitive proposals. Interested parties may identify their interest and capabilities in response to this requirement, within five (5) calendar days from publication date of this synopsis or by August 26, 2009 at 7:30am Eastern Standard Time. The determination by the Government not to compete the proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct future competitive procurement. Responses to this announcement, referencing synopsis number NHLBI-PB(HL)-2009-269-DDC may be submitted to the National Heart, Lung and Blood Institute, Consolidated Operations Acquisition Center, Procurement Branch, 6701 Rockledge Drive, Suite 6142, Bethesda, Maryland 20892-7902, Attention Deborah Coulter. Response may be submitted electronically to [email protected]. Responses will only be accepted if dated and signed by an authorized company representative. All responsible sources may submit a quotation, which if timely received, shall be considered by the agency

Bid Protests Not Available